17:44 Implementing treatment pathways for the management of ulcerative colitis and Crohn's disease HMP Education
18:02 Perspectives on immunomodulators and biologics: Risk of neoplasia and malignancy development HMP Education
18:43 Neurologic, rheumatologic, and optic complications related to immunomodulators and biologic HMP Education
24:47 Diagnosis and management of infections in IBD patients on immunomodulators and biologics HMP Education
17:56 Health maintenance in IBD: Prevention of infectious diseases due to immunosuppression HMP Education
25:33 Understanding the mechanisms of action of new agents: Implications for efficacy and safety HMP Education
21:36 How will future therapeutic pathways change for ulcerative colitis and Crohn's disease? HMP Education
20:04 Is there an optimal approach to prevent recurrence in post-operative Crohn's disease HMP Education
21:50 Challenges in clinical care: The volume of patients seen versus the value needed for each patient HMP Education
14:09 How can we best determine endoscopic severity in ulcerative colitis and Crohn's disease? HMP Education
18:59 Endoscopic resection of visible lesions and polyps in ulcerative colitis and Crohn's patients HMP Education
17:23 Are there alternative, complementary therapies that our patients will benefit from? HMP Education
